Drug
bictegravir/lenacapavir
Marketed as BIXLENVO.
Generic name
bictegravir/lenacapavir
Brand names
BIXLENVO
First FDA approval
2026-08-27
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA221104 | BIXLENVO | 2026-08-27 | GILEAD SCIENCES |
Manufacturers
GILEAD SCIENCES
Frequently asked questions
When was bictegravir/lenacapavir FDA approved?
Earliest FDA approval on record: 2026-08-27.
What brand names are sold as bictegravir/lenacapavir?
BIXLENVO.
Sources
Appeal a bictegravir/lenacapavir denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com